Q2 FY27 revenue up 16.2%, but consolidated loss widens

Management guided margin improvementInvestor Communications View source PDF Explain this filing

GEMAROMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.7%Reaction day

₹136.00

prior close

₹139.89

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%-0.7% vs market

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.3

10m

-2.8

15m

-3.5

30m

-2.5

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+0.7+1.4-0.7

Next day

+0.9+1.7-0.9

+3.6+3.9-0.3

+3.3+5.1-1.8

+0.9pendingpending

———

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gem Aromatics reported Q2 FY27 consolidated revenue of Rs 104.0 crore, up 16.2% year on year, and H1 revenue of Rs 202.8 crore, up 14.5%. Q2 gross margin rose to 25.4% and EBITDA margin to 7.6%. Higher depreciation from the new Dahej plant of Rs 9.5 crore drove a Q2 loss of Rs 7.0 crore and H1 loss of Rs 14.9 crore. Cooling agent shipments and Safranal production began, with initial revenue expected in Q3 FY27.

Likely market impact

Revenue growth and better Q2 margins help, but Dahej depreciation, H1 losses and cash flow pressure keep the near-term earnings outlook cautious.